CANC vs MEDX
Tema Oncology ETF vs Horizon Kinetics Medical ETF
Which is better, CANC or MEDX?
CANC has been ahead.
CANC has a lower expense ratio. CANC led over 1Y, 3Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | CANC | MEDX |
|---|---|---|
| Expense Ratio | 0.75%Best | 0.85% |
| AUM | $197M | $16M |
| Dividend Yield | 0.05% | 1.16% |
| Holdings | 118 | 68 |
| YTD Return | +14.86%Best | +6.58% |
| 1Y Return | +34.85%Best | +14.21% |
| 3Y Return (annualized) | +22.41%Best | +9.64% |
| Volatility (annualized) | 19.4% | 14.9%Best |
| Max Drawdown | -26.1% | -21.6%Best |
| $10,000 over 3.2 years | $16,937Best | $12,891 |
| Fund Family | Tema Global Limited | Horizon Kinetics LLC |
| Category | Equity | Equity |
| Style | Large Cap Blend | Large Cap Blend |
| Inception | Aug 15, 2023 | Jan 27, 2023 |
Not shown on this pair: 5Y Return (annualized), Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 3.2 years row, are measured over the window both funds cover: Aug 15, 2023 to Oct 14, 2026 (3.2 years).
CANC vs MEDX growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 3.2 years both funds cover.
CANC vs MEDX Performance
Tema Oncology ETF (CANC) is an ETF from Tema Global Limited and Horizon Kinetics Medical ETF (MEDX) is an ETF from Horizon Kinetics LLC. Over the past year CANC returned +34.85% while MEDX returned +14.21%. Year to date, CANC is up 14.86% versus a gain of 6.58% for MEDX.
Over three years, CANC compounded at +22.41% per year against +9.64% for MEDX.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
CANC has been the more volatile fund, with annualized monthly volatility of 19.4% compared with 14.9% for MEDX. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -26.1% for CANC and -21.6% for MEDX. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.81. They usually move together, but the gap leaves some room for diversification.
Fees and Cost Over Time
CANC charges 0.75% per year while MEDX charges 0.85%. On a $10,000 position that is $75 vs $85 annually, a gap of $10 per year that compounds over a long holding period. On income, CANC currently yields 0.05% against 1.16% for MEDX.
Holdings Overlap
At least 23.3% of CANC's money is in holdings MEDX also owns.
Stated as a floor: for MEDX, our book for it covers 91.6% of that fund, so a holding it does not list is one we cannot count as shared. The real figure is this or higher.
CANC and MEDX share little of their money.
8 positions in common, counted across the 59 positions we hold weights for in CANC and 31 in MEDX, against full books of 118 and 68.
Top Shared Holdings
| Stock | Weight in CANC | Weight in MEDX | Difference |
|---|---|---|---|
| LLYEli Lilly & Co. | 4.60% | 19.14% | 14.54% |
| ABBVAbbvie Inc. | 3.34% | 9.99% | 6.65% |
| MRKMerck & Company Inc | 4.86% | 4.60% | 0.26% |
| JNJJohnson & Johnson - Common | 2.95% | 5.96% | 3.01% |
| BMYBristol-Myers Squibb Co. | 3.45% | 4.32% | 0.87% |
| AZN:LNAstraZeneca PLC | 2.05% | 4.40% | 2.35% |
| AMGNAmgen Inc. | 1.30% | 4.67% | 3.37% |
| REPLReplimune Group Inc Com | 0.72% | 0.91% | 0.19% |
23.3% of CANC is already inside MEDX.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, CANC or MEDX?
CANC has an expense ratio of 0.75% while MEDX charges 0.85%. CANC is the cheaper option, by $10 a year on a $10,000 investment.
Which performed better, CANC or MEDX?
Over the past year CANC returned +34.85% vs +14.21% for MEDX, so CANC leads on 1-year performance. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, CANC or MEDX?
CANC has been the more volatile fund at 19.4% annualized versus 14.9% for MEDX. Worst drawdown: CANC -26.1% vs MEDX -21.6%.
Should I hold both CANC and MEDX?
CANC and MEDX have a monthly-return correlation of 0.81, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between CANC and MEDX?
At least 23.3% of CANC's money is in holdings MEDX also owns. Our book for MEDX is partial, so the real figure is this or higher. They hold 8 positions in common, counted across the 59 positions we hold weights for in CANC and 31 in MEDX.
Which pays a higher dividend, CANC or MEDX?
CANC yields 0.05% while MEDX yields 1.16%, so MEDX currently pays the higher dividend yield.
Is MEDX better than CANC?
CANC has a lower expense ratio. CANC led over 1Y, 3Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.